Carson Wealth (CWM LLC)’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,672
| Closed | -$9K | – | 5255 |
|
|
2024
Q2 | $9K | Sell |
1,672
-565
| -25% | -$3.04K | ﹤0.01% | 3638 |
|
|
2024
Q1 | $12K | Sell |
2,237
-2,085
| -48% | -$11.2K | ﹤0.01% | 3252 |
|
|
2023
Q4 | $23K | Buy |
4,322
+3,258
| +306% | +$17.3K | ﹤0.01% | 2708 |
|
|
2023
Q3 | $17K | Buy |
1,064
+484
| +83% | +$7.73K | ﹤0.01% | 2810 |
|
|
2023
Q2 | $11K | Buy |
580
+454
| +360% | +$8.61K | ﹤0.01% | 3044 |
|
|
2023
Q1 | $4K | Sell |
126
-110
| -47% | -$3.49K | ﹤0.01% | 3443 |
|
|
2022
Q4 | $7K | Buy |
236
+68
| +40% | +$2.02K | ﹤0.01% | 3038 |
|
|
2022
Q3 | $4K | Buy |
+168
| New | +$4K | ﹤0.01% | 3239 |
|